UNSPSC 51334313: Flupentixol dihydrochloride

This classification denotes a serotonin antagonist and dopamine antagonist with the molecular formula C23H25F3N2OS.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 96L0Z069N1, chemically known as 1-piperazineethanol, 4-(3-(2-(trifluoromethyl)-9h-thioxanthen-9-ylidene)propyl)-, (e)- but more generally known as flupentixol dihydrochloride, which bears US NIH Compound Identifier 5281878.

European Medicines Agency schedules Flupentixol dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02229MIG. Most nations, for tariff and trade purposes, schedule flupentixol dihydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, FLUPENTIXOL DIHYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC2C(C1)/C(=C/CCN3CCN(CC3)CCO)/C4CC(CCC4S2)C(F)(F)F.CL.CL.

UNSPSC 51334313 Flupentixol dihydrochloride is a Commodity code that does not align with the recent state and local procurement activity captured under it. The code nominally describes a pharmaceutical antipsychotic agent, but the single recent opportunity tagged to this code solicits naloxone and safe drug deactivation systems—medications and equipment used in opioid overdose response and drug disposal, not antipsychotic treatment. The mismatch suggests either a data-entry error in the opportunity classification or that this code is not in active use for state and local procurement.

Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 seeking to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with a response deadline of July 26, 2023. The procurement requires quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with bidders responsible for all shipping costs. The contract carries a two-year initial term with a one-year renewal option, requires drug-free workplace certification and E-Verify compliance, and is potentially funded through FEMA, introducing federal environmental compliance requirements. The opportunity represents community health support rather than pharmaceutical supply aligned with the code's nominal scope, and no other recent state or local opportunities appear under this code.